Figures
Abstract
Background
This study investigates the differences between patients with and without obstructive sleep apnea (OSA) in U.S. emergency departments (EDs), focusing on demographics, resource utilization, clinical characteristics, and outcomes.
Methods
Using data from the 2016−2017 National Hospital Ambulatory Medical Care Survey Emergency Department Subfile (NHAMCS-ED), we analyzed adult ED visits. Patients were classified as having OSA based on documented diagnoses or ICD-10-CM codes. Outcomes included hospital and ICU admission rates, medical resource utilization (e.g., imaging, blood tests), and mortality. Logistic regression was used to adjust for confounders.
Results
OSA accounted for approximately 5,985,955 (2.8%) annual ED visits. Compared to non-OSA patients, those with OSA were more likely to be male (adjusted OR: 1.34, 95% CI: 1.14–1.57) and older, with the highest prevalence in the 60–74 age group. OSA patients were more likely to visit for respiratory (16.4% vs. 10.1%) and cardiovascular symptoms (3.5% vs. 2.1%). They required higher levels of care, with elevated hospital (30.3% vs. 13.7%, adjusted OR: 1.27, 95% CI: 1.03–1.58). Resource use was significantly higher, including blood tests (75.0% vs. 54.9%, adjusted OR: 1.58, 95% CI: 1.26–1.98) and imaging (73.1% vs. 53.9%, adjusted OR: 1.30, 95% CI: 1.07–1.59).
Citation: Sun M, Zhang X, Liu Y-C, Pei J, Fan H, Guo J (2025) Clinical characteristics and resource utilization of emergency department patients with obstructive sleep apnea. PLoS One 20(6): e0326194. https://doi.org/10.1371/journal.pone.0326194
Editor: Yongzhong Guo, Xuzhou Central Hospital, The Xuzhou School of Clinical Medicine of Nanjing Medical University, CHINA
Received: January 14, 2025; Accepted: May 26, 2025; Published: June 17, 2025
Copyright: © 2025 Sun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All dataset files are available from the the NHAMCS-ED dataset (https://www.cdc.gov/nchs/ahcd/index.htm).
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Background
Obstructive sleep apnea (OSA) is a prevalent and growing public health concern worldwide, with its incidence closely tied to rising obesity rates [1,2]. This sleep disorder is characterized by repetitive upper airway obstruction during sleep, leading to intermittent hypoxia, fragmented sleep, and significant physiological stress [3]. OSA is associated with various adverse health outcomes, including hypertension [4,5], diabetes [6,7], cardiovascular [8,9] disease, and increased risk of traffic accidents [10–12], which collectively contribute to substantial morbidity, mortality, and economic burden [13–15].
In the United States, OSA affects an estimated 2–4% of the general population, although the true prevalence is likely much higher due to underdiagnosis [16,17]. Despite its significant health implications, only a fraction of individuals with OSA receive appropriate diagnosis and treatment [18]. This gap in care not only exacerbates the disease burden but also places strain on healthcare systems, particularly emergency departments (EDs), which serve as critical access points for acute medical care.
Previous research has primarily focused on OSA’s associations with comorbid conditions, diagnostic strategies, and treatment interventions [1,3,4,6]. However, limited attention has been given to understanding the unique characteristics and healthcare needs of ED patients with OSA. Exploring these differences is essential for tailoring emergency care strategies, optimizing resource allocation, and improving patient outcomes.
This study aims to address this knowledge gap by analyzing the demographics, clinical characteristics, resource utilization, and outcomes of ED visits by patients with OSA compared to those without OSA. Using data from the nationally representative 2016–2017 National Hospital Ambulatory Medical Care Survey Emergency Department Subfile (NHAMCS-ED), we seek to determine whether OSA patients require distinct consideration in ED settings and to identify opportunities for improving their care pathways.
Method
This study utilized data from the 2016–2017 NHAMCS-ED, a nationally representative survey conducted by the Centers for Disease Control and Prevention. The NHAMCS-ED employs a multistage, stratified sampling design to capture comprehensive information on emergency department (ED) visits from approximately 300 hospital-based EDs across the United States. The study population included all adult patients aged 18 years and older, comprising a total of 27,609 ED visits.
Patients were classified as having obstructive sleep apnea (OSA) if their ED records included an explicit OSA diagnosis or the International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) code G47.3 (Sleep Apnea) in one of the provider diagnosis fields. The primary outcome of interest was the presence of an OSA diagnosis during the ED visit. Secondary outcomes included emergency severity, measured by the Emergency Severity Index (ESI), a five-level triage scale that ranks patient acuity from immediate (level 1) to non-urgent (level 5). Additional outcomes were hospital and intensive care unit (ICU) admission rates, resource utilization metrics (including blood tests, imaging such as X-rays and CT scans, and procedures like BiPAP/CPAP or intubation), and clinical outcomes such as mortality or leaving the ED without treatment.
To investigate these outcomes, the study examined a comprehensive set of covariates to adjust for potential confounding. These included demographic characteristics (age, sex, race/ethnicity, and geographic region), socioeconomic factors (insurance type and residence type), and visit-specific variables (day of the week, arrival by ambulance, seen within the past 72 hours, and reported pain level). Clinical indicators such as vital signs (temperature, heart rate, blood pressure), and the primary reason for the ED visit were also included. In addition, major comorbid conditions—including coronary artery disease, cerebrovascular disease, congestive heart failure, obesity, and diabetes—were incorporated into the adjusted models to better account for underlying health status.
Descriptive statistics were used to compare characteristics between patients with and without OSA, and chi-square tests were performed to assess differences in categorical variables. Logistic regression models were then constructed to evaluate the associations between OSA and secondary outcomes while adjusting for covariates. Adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for each model to quantify the relationships. Missing data were handled using NHAMCS-ED’s sequential hot-deck imputation method for key variables, such as age and diagnosis codes, while median imputation was applied to other variables before running regression models. All statistical analyses were performed using SAS® software (Version 9.4), with a significance threshold set at a p-value of less than 0.05. To account for multiple comparisons, we applied the Benjamini-Hochberg procedure to control the false discovery rate (FDR) at 0.05. This method was selected to balance the control of Type I error with maintaining statistical power across multiple related outcome tests. P-values were adjusted accordingly, and outcomes that remained significant after FDR correction are indicated in the Results and tables.
The use of NHAMCS-ED’s robust design and statistical methods ensured the findings were nationally representative and accounted for potential confounding factors. This study utilized data from the National Hospital Ambulatory Medical Care Survey Emergency Department Subfile, a publicly available and fully anonymized dataset provided by the Centers for Disease Control and Prevention (CDC). As the data are de-identified and do not contain personally identifiable information, the study was exempt from ethics approval by the University of Pittsburgh Institutional Review Board under protocol STUDY24120115. No direct interaction with human participants occurred.
Results
In 2016–2017, there were approximately 215,240,000 adult ED visits in the United States, averaging 107.62 million visits annually. Among these, 5,985,955 visits (2.8%) were made by patients with OSA, equating to roughly 2,992,978 visits per year. Patients with OSA demonstrated distinct demographic and clinical characteristics compared to those without OSA. According to Table 1, they were more likely to be male (49.3% vs. 42.6%) and older, with the highest prevalence observed in individuals aged 60–74 years (30.5%), followed by those aged 50–59 years (23.9%) and 75 years or older (17.9%). Geographically, the Midwest had the largest proportion of OSA patients (34.8%), while the lowest proportion was seen in the West (15.3%). Race and ethnicity distributions did not differ significantly between the OSA and non-OSA groups. However, OSA patients were more likely to arrive at the ED by ambulance (30.7% vs. 18.4%) and to report severe pain levels at presentation (39.2% vs. 36.4%). In addition, patients with OSA were more likely to have obesity (31.3% vs. 4.6%), diabetes (44.9% vs. 14.4%), and cardiovascular diseases compared to those without OSA.
According to Table 2 and Supplement S1 Table, patients with OSA were more likely to present with specific symptoms compared to general symptoms. Respiratory symptoms were more common among OSA patients (16.4% vs. 10.1%), with an adjusted odds ratio (OR) of 1.25 (95% CI: 0.95–1.65). Similarly, cardiovascular and lymphatic symptoms were more frequently observed in OSA patients (3.5% vs. 2.1%), corresponding to an adjusted OR of 1.43 (95% CI: 0.93–2.21). These findings highlight the increased burden of respiratory and cardiovascular complications among OSA patients.
According to Tables 3 and 4, the analysis also revealed significantly higher medical resource utilization among OSA patients. Blood tests were performed in 75.0% of OSA cases, compared to 54.9% of non-OSA cases (adjusted OR: 1.58, 95% CI: 1.26–1.98). Imaging studies were more common in the OSA group, with 73.1% undergoing any imaging compared to 53.9% in the non-OSA group (adjusted OR: 1.30, 95% CI: 1.07–1.59). X-rays were performed in 56.1% of OSA cases versus 36.7% of non-OSA cases (adjusted OR: 1.29, 95% CI: 1.07–1.56). CT scans were also slightly more frequent in the OSA group (27.4% vs. 21.4%), although the adjusted OR (0.95, 95% CI: 0.77–1.77) did not reach statistical significance. Clinical outcomes further highlighted the severity of illness among OSA patients. These patients were significantly more likely to be classified as having a higher acuity level, with 26.0% assigned an Emergency Severity Index (ESI) score of 1 or 2 (immediate or emergent) compared to 14.6% of non-OSA patients (adjusted OR: 1.35, 95% CI: 1.02–1.77). Hospital admission rates were markedly higher in the OSA group (30.3% vs. 13.7%), with an adjusted OR of 1.27 (95% CI: 1.03–1.58).
Discussion
This study provides a comprehensive analysis of emergency department visits by patients with obstructive sleep apnea in the United States using nationally representative data from the NHAMCS-ED. Our findings reveal that while OSA accounts for a relatively small proportion of ED visits (2.8%), patients with OSA demonstrate distinct clinical characteristics, higher resource utilization, and significantly worse outcomes compared to patients without OSA. These results highlight the substantial burden OSA places on emergency care systems and underscore the need for improved management strategies for this population [19].
Patients with OSA in this study were more likely to present with respiratory or cardiovascular symptoms compared to general symptoms, consistent with the known associations of OSA with respiratory dysfunction and cardiovascular complications such as hypertension, arrhythmias, and heart failure. These findings align with previous research emphasizing the bidirectional relationship between OSA and chronic respiratory [20–23] and cardiovascular diseases [24–27]. For example, OSA-induced hypoxemia [28] and sympathetic overactivation [29] may exacerbate preexisting conditions, potentially explaining the higher acuity levels observed in our study. Furthermore, the increased prevalence of musculoskeletal symptoms among OSA patients warrants additional investigation, as these may reflect overlapping conditions like obesity-related joint pain or generalized fatigue and muscle weakness due to poor sleep quality.
From a healthcare resource perspective, our results indicate that ED patients with OSA utilize significantly more resources than their non-OSA counterparts. This includes nearly double the rate of blood tests and significantly higher rates of imaging, particularly X-rays and CT scans. The higher resource utilization observed in this group may reflect the complexity of managing OSA patients, who often present with multiple comorbidities requiring comprehensive evaluation [30]. These findings suggest that healthcare providers in ED settings should be prepared for the diagnostic and therapeutic challenges posed by OSA patients. The study also highlights stark differences in outcomes. Patients with OSA were significantly more likely to require hospital or ICU admission. These adverse outcomes underscore the severity of OSA-related health complications and the importance of early intervention and management.
Notably, the demographic analysis revealed that OSA disproportionately affects older adults and males, consistent with known epidemiological trends [31,32]. However, the lack of significant differences in OSA prevalence across racial and ethnic groups in this study contrasts with prior findings suggesting disparities in OSA diagnosis and treatment [33]. This discrepancy may reflect the limitations of administrative data or differences in how OSA is documented across populations.
Despite the robustness of our findings, this study has limitations. First, the identification of OSA relied on documented diagnoses or ICD-10-CM codes within the NHAMCS-ED dataset. The reliance on administrative data introduces the potential for misclassification or underdiagnosis of OSA [34], particularly for patients without a prior diagnosis who may not have been recognized as having the condition during their ED visit. In addition, information on OSA severity (e.g., mild, moderate, severe) and treatment status, such as adherence to positive airway pressure (PAP) therapy, was not available, limiting our ability to assess the impact of disease control on outcomes. Second, although we adjusted for important comorbidities including coronary artery disease, cerebrovascular disease, congestive heart failure, obesity, and diabetes in our regression models, the possibility of residual confounding cannot be completely ruled out. NHAMCS-ED lacks information on certain patient characteristics that may influence outcomes, such as smoking status, economic status, employment status, and detailed medication use. Third, while we included a variable indicating whether patients had visited the ED within the previous 72 hours, the dataset does not capture longer-term patterns of healthcare utilization, which could influence resource use and outcomes. Fourth, the NHAMCS-ED dataset captures only the index ED visit and immediate disposition outcomes (e.g., hospital admission, death during hospitalization) without long-term follow-up data. Thus, we were unable to assess outcomes beyond the ED stay or subsequent hospitalization. Finally, due to the cross-sectional design of NHAMCS-ED, causal relationships between OSA and healthcare utilization or outcomes cannot be inferred. Our findings reflect associations rather than causal effects. Future longitudinal studies are needed to better characterize the impact of OSA and its management on emergency care outcomes over time.
Conclusion
This study provides critical insights into the unique characteristics, resource needs, and outcomes of ED patients with OSA. Compared to patients without OSA, those with OSA exhibit higher acuity, greater resource utilization, and higher rates of hospital. These findings underscore the importance of improving the recognition and management of OSA in emergency settings [35,36]. To address the challenges identified in this study, healthcare systems should consider implementing targeted strategies to optimize care for OSA patients [37–39]. Potential interventions for future research include the development of ED-based OSA screening protocols, such as the STOP-BANG questionnaire, to identify high-risk patients who may otherwise go undiagnosed. Integration of automated flagging systems within electronic health records (EHRs) for patients with a known diagnosis of OSA could assist ED providers in recognizing individuals at elevated risk for complications. In addition, the creation of targeted care pathways—such as expedited respiratory therapy evaluations, early initiation of non-invasive ventilation, or referral to outpatient sleep specialists—may improve both immediate and long-term outcomes. Future studies should evaluate the feasibility, effectiveness, and cost-efficiency of these interventions in ED environments. Broader efforts, such as multidisciplinary approaches to managing OSA comorbidities, enhanced provider education on OSA-related complications, and public health initiatives promoting early diagnosis and treatment in outpatient settings, could also reduce the burden of OSA on emergency care systems. Longitudinal research is needed to explore the long-term outcomes of ED patients with OSA and to assess the impact of targeted management strategies. By addressing these gaps, we can better support patients with OSA, alleviate their clinical and economic burden, and enhance the overall efficiency and quality of emergency care delivery.
Supporting information
S1 Table. Association Between OSA Status in ED Patients and Their Visiting Characteristics (NHAMCS 2016–2017).
https://doi.org/10.1371/journal.pone.0326194.s001
(DOCX)
References
- 1. Bonsignore MR. Obesity and obstructive sleep apnea. Handb Exp Pharmacol. 2022;274:181–201.
- 2. Wyszomirski K, Walędziak M, Różańska-Walędziak A. Obesity, bariatric surgery and obstructive sleep apnea-A narrative literature review. Medicina (Kaunas). 2023;59(7):1266. pmid:37512076
- 3. Iannella G, Magliulo G, Greco A, de Vincentiis M, Ralli M, Maniaci A, et al. Obstructive sleep apnea syndrome: from symptoms to treatment. Int J Environ Res Public Health. 2022;19(4):2459. pmid:35206645
- 4. Brown J, Yazdi F, Jodari-Karimi M, Owen JG, Reisin E. Obstructive sleep apnea and hypertension: updates to a critical relationship. Curr Hypertens Rep. 2022;24(6):173–84. pmid:35246797
- 5. Seravalle G, Grassi G. Sleep apnea and hypertension. High Blood Press Cardiovasc Prev. 2022;29(1):23–31.
- 6. Bloomgarden Z. Obstructive sleep apnea and diabetes. J Diabetes. 2023;15(11):916–9. pmid:37926432
- 7. Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: a state of the art review. Chest. 2017;152(5):1070–86. pmid:28527878
- 8. Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e56–67. pmid:34148375
- 9. O’Donnell C, O’Mahony AM, McNicholas WT, Ryan S. Cardiovascular manifestations in obstructive sleep apnea: current evidence and potential mechanisms. Pol Arch Intern Med. 2021;131(6):550–60. pmid:34184854
- 10. Udholm N, Rex CE, Fuglsang M, Lundbye-Christensen S, Bille J, Udholm S. Obstructive sleep apnea and road traffic accidents: a Danish nationwide cohort study. Sleep Med. 2022;96:64–9. pmid:35605348
- 11. Pocobelli G, et al. Obstructive sleep apnea and risk of motor vehicle accident. Sleep Med. 2021;85:196–203.
- 12. Felix M, Intriago Alvarez MB, Vanegas E, Farfán Bajaña MJ, Sarfraz Z, Sarfraz A, et al. Risk of obstructive sleep apnea and traffic accidents among male bus drivers in Ecuador: Is there a significant relationship? Ann Med Surg (Lond). 2022;74:103296. pmid:35145670
- 13. Alakorkko I, et al. The economic cost of obstructive sleep apnea: A systematic review. Sleep Med Rev. 2023;72:101854.
- 14. Kawada T. Obstructive sleep apnea and mortality: a risk assessment. Sleep Breath. 2024;28(4):1857–8. pmid:38743324
- 15. Grewal N, Gordon D, Bajaj S, Gyimah C, Hassan M, Fatima U, et al. Impact of obstructive sleep apnea treatment on cardiovascular disease associated mortality and morbidity: a systematic review. Curr Probl Cardiol. 2024;49(1 Pt C):102139. pmid:37863463
- 16. Madhumathi R, Aashik , Yadav S, Karthik . To screen for obstructive sleep apnoea in type 2 diabetes and its correlation with Hscrp levels and microvascular complications. J Assoc Physicians India. 2022;70(4):11–2. pmid:35443369
- 17. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323(14):1389–400. pmid:32286648
- 18. Kirsch DB. Obstructive sleep apnea. Continuum (Minneap Minn). 2020;26(4):908–28. pmid:32756228
- 19. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–98. pmid:31300334
- 20. McNicholas WT, Hansson D, Schiza S, Grote L. Sleep in chronic respiratory disease: COPD and hypoventilation disorders. Eur Respir Rev. 2019;28(153):190064. pmid:31554703
- 21. Hong P-Y, Liu D, Liu A, Su X, Zhang X-B, Zeng Y-M. Causal associations of obstructive sleep apnea with chronic respiratory diseases: a Mendelian Randomization study. BMC Pulm Med. 2024;24(1):409. pmid:39187806
- 22. Locke BW, Lee JJ, Sundar KM. OSA and chronic respiratory disease: mechanisms and epidemiology. Int J Environ Res Public Health. 2022;19(9):5473. pmid:35564882
- 23. Ioachimescu OC, McNicholas WT. Chronic obstructive pulmonary disease-obstructive sleep apnea overlap: more than a casual acquaintance. Am J Respir Crit Care Med. 2022;206(2):139–41. pmid:35549667
- 24. Bouzerda A. Cardiovascular risk and obstructive sleep apnea. Pan Afr Med J. 2018;29:47. pmid:29875929
- 25. Catalan Serra P, Soler X. Obstructive sleep apnea and cardiovascular events in elderly patients. Expert Rev Respir Med. 2022;16(2):197–210. pmid:35041560
- 26. Redline S, Azarbarzin A, Peker Y. Obstructive sleep apnoea heterogeneity and cardiovascular disease. Nat Rev Cardiol. 2023;20(8):560–73. pmid:36899115
- 27. Li YE, Ren J. Association between obstructive sleep apnea and cardiovascular diseases. Acta Biochim Biophys Sin (Shanghai). 2022;54(7):882–92. pmid:35838200
- 28. Borsini E, Nigro C. Hypoxemia and hypertension in obstructive sleep apnea: the forgotten variable. J Bras Pneumol. 2023;49(1):e20220314. pmid:36753214
- 29. Alomri RM, Kennedy GA, Wali SO, Alhejaili F, Robinson SR. Association between nocturnal activity of the sympathetic nervous system and cognitive dysfunction in obstructive sleep apnoea. Sci Rep. 2021;11(1):11990. pmid:34099794
- 30. Huh G, Han K do, Park Y-M, Park C-S, Lee K-N, Lee EY, et al. Comorbidities associated with high-risk obstructive sleep apnea based on the STOP-BANG questionnaire: a nationwide population-based study. Korean J Intern Med. 2023;38(1):80–92. pmid:36353789
- 31. Fietze I, Laharnar N, Obst A, Ewert R, Felix SB, Garcia C, et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend. J Sleep Res. 2019;28(5):e12770. pmid:30272383
- 32. Bonsignore MR, Saaresranta T, Riha RL. Sex differences in obstructive sleep apnoea. Eur Respir Rev. 2019;28(154):190030. pmid:31694839
- 33. Wang VH-C, Li Y, Kent DT, Pagán JA, Arabadjian M, Divers J, et al. Racial and ethnic differences in the receipt of continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Med. 2024;124:42–9. pmid:39276697
- 34. Whyte A, Gibson D. Adult obstructive sleep apnoea: Pathogenesis, importance, diagnosis and imaging. J Med Imaging Radiat Oncol. 2020;64(1):52–66. pmid:31788980
- 35. Pan Z, Liao S, Sun W, Zhou H, Lin S, Chen D, et al. Screening and early warning system for chronic obstructive pulmonary disease with obstructive sleep apnoea based on the medical Internet of Things in three levels of healthcare: protocol for a prospective, multicentre, observational cohort study. BMJ Open. 2024;14(2):e075257. pmid:38418236
- 36. Evans EC, Sulyman O, Froymovich O. The goals of treating obstructive sleep apnea. Otolaryngol Clin North Am. 2020;53(3):319–28. pmid:32334878
- 37. Donovan LM, et al. Redesigning care for OSA. Chest. 2020;157(4):966–76.
- 38. Johnson KG, Lindenauer PK. Failure of PAP therapy to alter the trajectory of health care utilization among patients with OSA: a wake-up call for the field of sleep medicine or just a bad dream? Med Care. 2018;56(11):899–900. pmid:30256280
- 39. Lloyd R, Morgenthaler TI, Donald R, Gray DD, Lewin D, Revana A, et al. Quality measures for the care of adult patients with obstructive sleep apnea: 2022 update after measure maintenance. J Clin Sleep Med. 2022;18(11):2673–80. pmid:36308029